Welcome to Medications.com
Clonidine Hydrochloride News
Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for ... - PR Newswire (press release)
Addrenex has moved swiftly to develop and commercialize CloniBID, a sustained-release formulation of clonidine hydrochloride. The company recently entered ...
http://sev.prnewswire.com/medical... |
Posted: Wed Feb 20 14:04:16 -0500 2008
Sciele Pharma, Inc. Reports Results for Fourth Quarter and Year ... - FOXBusiness
CloniBID and Clonicel are both a 12-hour, sustained-release formulation of clonidine hydrochloride. The patient enrollment for the Phase III trials using ...
http://www.foxbusiness.com/market... |
Posted: Wed Feb 27 12:08:49 -0500 2008
Sciele Pharma, Inc. Reports Revenues and Earnings for the Second ... - Business Wire (press release)
Clonicel is a 12-hour, sustained release formulation of clonidine hydrochloride. In May 2007, the Company licensed from Plethora Solutions PSD502, ...
Posted: Wed Jul 25 13:04:53 -0400 2007
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to ... - PharmaLive.com (press release)
Clonidine hydrochloride is an alpha-2 agonist approved for the treatment of hypertension. During the past year, approximately 11.7 million prescriptions ...
http://www.pharmalive.com/News/in... |
Posted: Thu Jul 12 06:00:13 -0400 2007
Clonidine Hydrochloride
Clonidine Hydrochloride RSS FeedFrequently Reported Side Effects of Clonidine Hydrochloride
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
